The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Retrospective study regarding the efficacy of second- or higher-line chemotherapy (CT) of patients in advanced or recurrent gastric cancer (ARGC) after the failure of S-1 or S-1 combination chemotherapy (S+α).
Kazuma Kobayashi
No relevant relationships to disclose
Yuji Negoro
No relevant relationships to disclose
Yasuhiro Hata
No relevant relationships to disclose
Sojiro Morita
No relevant relationships to disclose
Keisuke Aiba
No relevant relationships to disclose
Akihito Tsuji
No relevant relationships to disclose